AI assistant
Sending…
ANAPTYSBIO, INC — Director's Dealing 2017
Aug 21, 2017
32596_dirs_2017-08-21_d07cf754-42c0-4312-b4fa-cb3f3a732b2d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-08-21
Reporting Person: Novo Holdings A/S (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-21 | Common Stock | S | 356300 | $21.1009 | Disposed | 1936604 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.10 to $22.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
More from ANAPTYSBIO, INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
Apr 20
Director's Dealing
2026
Mar 28
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Jan 16
Director's Dealing
2026
Jan 16